Van Minh Huynh, Lan Viet Nguyen, Sinh Cao Thuc, Hung Phan Nam, Ngoc Nguyen Thi Mong, Van Hung Ngo, Son Tran Kim, Đong Nguyen Ta, Thang Đoan Chi, Thuan Nguyen Duc, Dinh Thoan Nguyen, Tien Hoang Anh, Beaney Thomas, Ster Anca Chis, Poulter Neil R
Department of Cardiology, University of Medicine and Pharmacy, Hue University, 6 Ngo Quyen, Hue City 530000, Vietnam.
Department of Cardiology, Vietnam Heart Institute, 1 Ton that Tung, Hanoi 100000, Vietnam.
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H139-H141. doi: 10.1093/eurheartj/suaa049. Epub 2020 Aug 28.
Vietnam in the Asia Pacific region has a high hypertension (HTN) prevalence. The May Measurement Month (MMM) program was enthusiastically responded to in Vietnam by launching and deploying it across the whole country from 2017. The aims of the MMM 2018 program in Vietnam were to screen at least 15 000 people aged 18 and over across the country; to inform participants of the risks associated with HTN; and thereby define the proportion of subjects with elevated blood pressure (BP) and assess the awareness and the effectiveness of its treatment. An opportunistic cross-sectional survey of volunteers aged ≥ 18 was carried out in May 2018. Blood pressure measurement, the definition of HTN, and statistical analysis followed the standard MMM protocol. From May 2018 to June 2018, through 10 cities/provinces in Vietnam, 17 332 individuals with mean age 47.0 ± 17.9 years were screened during MMM18. After multiple imputation, 5260 (30.3%) had HTN. Of individuals not receiving antihypertensive medication, 1956 (13.9%) were hypertensive. Of patients receiving antihypertensive medication, 1540 (46.6%) had uncontrolled BP. Those who had HTN also displayed many additional risk factors similarly to MMM 2017 including smoking, alcohol, overweight-obesity, and diabetes. In conclusion, MMM 2018 campaign is a continuation program of MMM 2017 that has promoted the strength of the BP screening survey in the community in Vietnam, which hopefully will influence on awareness of disease prevention in this century. The next steps of the program will have special innovations on how to reduce the frequency of focusing on variable risk factors to change the overall picture of HTN in Vietnam.
亚太地区的越南高血压患病率很高。2017年，越南积极响应“五月测量月”（MMM）项目，并在全国范围内启动和推广。2018年越南MMM项目的目标是在全国筛查至少15000名18岁及以上的人群；告知参与者与高血压相关的风险；从而确定血压升高（BP）受试者的比例，并评估其知晓率及其治疗效果。2018年5月对年龄≥18岁的志愿者进行了一项机会性横断面调查。血压测量、高血压的定义和统计分析均遵循标准的MMM方案。2018年5月至2018年6月，通过越南的10个城市/省份，在MMM18期间筛查了17332名平均年龄为47.0±17.9岁的个体。经过多重插补后，5260人（30.3%）患有高血压。在未接受抗高血压药物治疗的个体中，1956人（13.9%）患有高血压。在接受抗高血压药物治疗的患者中，1540人（46.6%）血压未得到控制。患有高血压的人还表现出许多其他风险因素，与2017年MMM类似，包括吸烟、饮酒、超重肥胖和糖尿病。总之，2018年MMM活动是2017年MMM的延续项目，该项目提升了越南社区血压筛查调查的力度，有望影响本世纪疾病预防的知晓率。该项目的下一步将在如何减少关注可变风险因素的频率以改变越南高血压总体状况方面有特殊创新。
